Affiliations

• ¹ Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
• ² Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
• ³ Stevens-Johnson Syndrome Foundation, Westminster, CO, USA.
• ⁴ Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
• ⁵ Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base, TX, USA.
• ⁶ Drug Hypersensitivity Group. Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
• ⁷ Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
• ⁸ Loyola University Medical Center, Chicago, IL, USA.
• ⁹ School of Pharmacy and Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
• ¹⁰ SJS Awareness Oregon, Klamath Falls, OR, USA.
• ¹¹ Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
• ¹² Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA.
• ¹³ National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, USA.
• ¹⁴ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ¹⁵ Genome Canada, Ottawa, ON, Canada.
• ¹⁶ Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
• ¹⁷ Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada.
• ¹⁸ Canadian Institutes of Health Research, Ottawa, ON, Canada.
• ¹⁹ Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
• ²⁰ Children's Mercy Hospital Kansas City, Kansas City, MO, USA.
• ²¹ Wake Forest University School of Medicine, WFBMC Burn Center, Winston-Salem, NC, USA.
• ²² Genome British Columbia, Vancouver, BC, Canada.
• ²³ Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan.
• ²⁴ Eden Social Welfare Foundation, Taipei, Taiwan.
• ²⁵ Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada.
• ²⁶ Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea.
• ²⁷ Department of Medicine, University of Washington, Seattle, WA, USA.
• ²⁸ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ²⁹ Association des malades des syndromes de Lyell et de Stevens-Johnson (Amalyste), Paris, France.
• ³⁰ Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
• ³¹ Health Products and Food Branch, Health Canada, Ottawa, ON, Canada.
• ³² SJS/TEN International Awareness (STIA), Lucky Lake, SK, Canada.
• ³³ Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ³⁴ Dokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology, Medical Center and Medical Faculty, University of Freiburg, Freiburg, Germany.
• ³⁵ SJ Syndrome of Texas, Austin, TX, USA.
• ³⁶ Laboratory of Immunology, Division of Biotechnology Review and Research III (DBRR III), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA.
• ³⁷ Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
• ³⁸ Department of Der matology, MedStar Washington Hospital Center, Washington, DC, USA.
• ³⁹ Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
• ⁴⁰ Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
• ⁴¹ Department of Paediatrics, Children's Hospital/London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
• ⁴² Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada.
• ⁴³ Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, TN, USA.
• ⁴⁴ Dutch Medicines Evaluation Board, Pharmacovigilance Risk Assessment Committee, European Medicines Agency, Utrecht, Netherlands.
• ⁴⁵ Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
• ⁴⁶ Health Products Regulation Group, Health Sciences Authority Singapore, Duke-NUS Medical School, Singapore.
• ⁴⁷ Department of Infectious Diseases, Austin Health, Heidelberg, Germany; Department of Medicine, University of Melbourne, Victoria, Australia.
• ⁴⁸ Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Pre fectural University of Medicine, Kyoto, Japan.
• ⁴⁹ National Human Genome Research Institute, NIH, Bethesda, ML, USA.
• ⁵⁰ Institute of Dermatology, Chinese Academy of Medical Sciences, National Center for STD and Leprosy Control, China CDC, Nanjing, China.
• ⁵¹ Division of Pharmacovigilance I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, USA.
• ⁵² SJS Canada, Brantford, ON, Canada.
• ⁵³ National Institute of Allergy and Infectious Diseases, NIH, Bethesda, ML, USA.
• ⁵⁴ Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
• ⁵⁵ Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁵⁶ Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, Keelung, Taoyuan, Taiwan; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China.
• ⁵⁷ Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
• ⁵⁸ Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada. Electronic address: bcarleton@popi.ubc.ca.